new obesity drug, Meridia
April 2001
Knoll is now shipping their new obesity drug, Meridia.
Meridia (sibutramine) curbs appetite by inhibiting the reuptake of norepinephrine and serotonin...and, to a lesser extent, dopamine.
This helps patients stick to a low-calorie diet...and lose about 5% to 10% of their body weight.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive